In the latest trading session, 0.42 million Conduit Pharmaceuticals Inc (NASDAQ:CDT) shares changed hands as the company’s beta touched 2.23. With the company’s most recent per share price at $0.86 changed hands at -$0.11 or -11.37% at last look, the market valuation stands at $4.07M. CDT’s current price is a discount, trading about -45481.4% off its 52-week high of $392.00. The share price had its 52-week low at $0.97, which suggests the last value was -12.79% down since then. When we look at Conduit Pharmaceuticals Inc’s average trading volume, we note the 10-day average is 0.94 million shares, with the 3-month average coming to 3.77 million.
Conduit Pharmaceuticals Inc (NASDAQ:CDT) trade information
Instantly CDT was in red as seen in intraday trades today. With action -21.49%, the performance over the past five days has been red. The company’s shares are showing year-to-date downside of -87.41%, with the 5-day performance at -21.49% in the red. However, in the 30-day time frame, Conduit Pharmaceuticals Inc (NASDAQ:CDT) is -34.07% down. Looking at the short shares, we see there were 0.45 million shares sold at short interest cover period of 0.06 days.
Conduit Pharmaceuticals Inc (NASDAQ:CDT)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 13.92% of Conduit Pharmaceuticals Inc shares while 2.41% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 2.80%. There are 2.41% institutions holding the Conduit Pharmaceuticals Inc stock share, with NEW YORK STATE COMMON RETIREMENT FUND the top institutional holder. As of 2024-06-30, the company held 0.0027% of the shares, roughly 98100.0 CDT shares worth $0.1 million.
MARSHALL WACE, LLP holds the second largest percentage of outstanding shares, with 0.0016% or 59728.0 shares worth $63312.0 as of 2024-06-30.
Among Mutual Funds, the top two as of Dec 31, 2024 were Fidelity Small Cap Index Fund and Vanguard Extended Market Index Fund. With 4.03 shares estimated at $3710.0 under it, the former controlled 0.11% of total outstanding shares. On the other hand, Vanguard Extended Market Index Fund held about 0.06% of the shares, roughly 2.03 shares worth around $1866.0.
